Alembic Pharma’s Vadodara unit passes FDA test with VAI remark

Voluntary action indicated (VAI) is suggested when violations are found, but the problems do not justify further regulatory action. Shares of Alembic Pharmaceuticals Ltd ended at ₹809, down by ₹17.20, or 2.08%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *